Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-aminopyridine for Nerve Injury Resulting From Radical Prostatectomy
NCT03701581Phase 3Recruiting
- Start
- Jun 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalfampridine in nerve injury. Started Jun 2021; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
nerve injury
Beyond the preview
Go deeper on NCT03701581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701581.